Screener
Inhibrx Biosciences, Inc. INBX Business Segments
| Q2 '26 | Q3 '25 | Q2 '25 | Q4 '24 | Q3 '24 | ||
|---|---|---|---|---|---|---|
| Total Revenue by Product | ||||||
| License fee revenue | $0-100% | $0— | $1.3M+1,200% | $100K-93.9% | $0-100% | |
| License fee revenue | $0-100% | —— | $1.3M+1,200% | —— | $0-100% |
FAQ
- How does Inhibrx Biosciences, Inc. break its business down?
- Inhibrx Biosciences, Inc. (INBX) reports total revenue by product across 2 parts — License fee revenue and License fee revenue. Each is extracted from the segment footnotes and tracked over time.
- Where does Inhibrx Biosciences, Inc.'s segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Inhibrx Biosciences, Inc.'s SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
